Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Generation of an LFA-1 Antagonist by the Transfer of the ICAM-1 Immunoregulatory Epitope to a Small Molecule
T. R. Gadek,*D. J. Burdick,*R. S. McDowell,M. S. Stanley,J. C. Marsters Jr.,K. J. Paris,D. A. Oare,M. E. Reynolds,C. Ladner,K. A. Zioncheck,W. P. Lee,P. Gribling,M. S. Dennis,N. J. Skelton,D. B. Tumas,K. R. Clark,S. M. Keating,M. H. Beresini,J. W. Tilley,L. G. Presta,S. C. Bodary
The protein-protein interaction between leukocyte
functional antigen-1 (LFA-1) and intercellular adhesion molecule-1
(ICAM-1)is critical to lymphocyte and immune system function. Here, wereport on the transfer of the contiguous, nonlinear epitope ofICAM-1,
responsible for its association with LFA-1, to a small-moleculeframework. These LFA-1 antagonists bound LFA-1, blocked bindingof
ICAM-1, and inhibited a mixed lymphocyte reaction (MLR) withpotency
significantly greater than that of cyclosporine A. Furthermore,in
comparison to an antibody to LFA-1, they exhibited significantanti-inflammatory effects in vivo. These results demonstrate theutility of small-molecule mimics of nonlinear protein epitopesand the
protein epitopes themselves as leads in the identificationof novel
pharmaceutical agents.
Departments of 1Bioorganic Chemistry,
2Immunology, 3Protein Engineering,
4Pathology, 5Small Molecule Pharmacology, and
7Antibody Technology, Genentech, One DNA Way, South San
Francisco, CA 94080, USA. 6Roche Research Center,
Hoffmann-La Roche, Nutley, NJ 07110, USA.
*
To whom correspondence should be addressed. E-mail:
trg{at}gene.com (T.R.G.); burdick.dan{at}gene.com (D.J.B.)
Present address: Sunesis Pharmaceuticals, 341 Oyster
Point Boulevard, South San Francisco, CA 94080, USA.
Present address: Gilead Sciences, 333 Lakeside Drive,
Foster City, CA 94404, USA.
LFA-1 Affinity Regulation Is Necessary for the Activation and Proliferation of Naive T Cells.
Y. Wang, D. Li, R. Nurieva, J. Yang, M. Sen, R. Carreno, S. Lu, B. W. McIntyre, J. J. Molldrem, G. B. Legge, et al. (2009)
J. Biol. Chem.
284, 12645-12653
|Abstract »|Full Text »|PDF »
A Small Molecule Agonist of an Integrin, {alpha}Lbeta2.
W. Yang, C. V. Carman, M. Kim, A. Salas, M. Shimaoka, and T. A. Springer (2006)
J. Biol. Chem.
281, 37904-37912
|Abstract »|Full Text »|PDF »
Targeting protein-protein interactions by rational design: mimicry of protein surfaces.
Rational Design of Anticytoadherence Inhibitors for Plasmodium falciparum Based on the Crystal Structure of Human Intercellular Adhesion Molecule 1.
M. Dormeyer, Y. Adams, B. Kramer, S. Chakravorty, M. T. Tse, S. Pegoraro, L. Whittaker, M. Lanzer, and A. Craig (2006)
Antimicrob. Agents Chemother.
50, 724-730
|Abstract »|Full Text »|PDF »
Spermine, a Natural Polyamine, Suppresses LFA-1 Expression on Human Lymphocyte.
K. Soda, Y. Kano, T. Nakamura, K. Kasono, M. Kawakami, and F. Konishi (2005)
J. Immunol.
175, 237-245
|Abstract »|Full Text »|PDF »
Scanning Mutagenesis of {omega}-Atracotoxin-Hv1a Reveals a Spatially Restricted Epitope That Confers Selective Activity against Insect Calcium Channels.
H. W. Tedford, N. Gilles, A. Menez, C. J. Doering, G. W. Zamponi, and G. F. King (2004)
J. Biol. Chem.
279, 44133-44140
|Abstract »|Full Text »|PDF »
The Binding Sites for Competitive Antagonistic, Allosteric Antagonistic, and Agonistic Antibodies to the I Domain of Integrin LFA-1.
C. Lu, M. Shimaoka, A. Salas, and T. A. Springer (2004)
J. Immunol.
173, 3972-3978
|Abstract »|Full Text »|PDF »
Loss of LFA-1, but not Mac-1, Protects MRL/MpJ-Faslpr Mice from Autoimmune Disease.
C. G. Kevil, M. J. Hicks, X. He, J. Zhang, C. M. Ballantyne, C. Raman, T. R. Schoeb, and D. C. Bullard (2004)
Am. J. Pathol.
165, 609-616
|Abstract »|Full Text »|PDF »
ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin alpha vbeta 3 and Induces Blood Vessel Formation in Vivo.
G. Camenisch, M. T. Pisabarro, D. Sherman, J. Kowalski, M. Nagel, P. Hass, M.-H. Xie, A. Gurney, S. Bodary, X. H. Liang, et al. (2002)
J. Biol. Chem.
277, 17281-17290
|Abstract »|Full Text »|PDF »